These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 27487812

  • 21. Evidence that fibrinolytic changes in paediatric obesity translate into a hypofibrinolytic state: relative contribution of TAFI and PAI-1.
    Semeraro F, Giordano P, Faienza MF, Cavallo L, Semeraro N, Colucci M.
    Thromb Haemost; 2012 Aug; 108(2):311-7. PubMed ID: 22740053
    [Abstract] [Full Text] [Related]

  • 22. Coagulation defects in thalassemic patients.
    Abosdera MM, Almasry AE, Abdel-Moneim ES.
    Pediatr Neonatol; 2017 Oct; 58(5):421-424. PubMed ID: 28351558
    [Abstract] [Full Text] [Related]

  • 23. Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis.
    Kaftan O, Balcik OS, Cipil H, Ozet G, Bavbek N, Koşar A, Dagdas S.
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):449-54. PubMed ID: 16244771
    [Abstract] [Full Text] [Related]

  • 24. Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy.
    Mousa HA, Downey C, Alfirevic Z, Toh CH.
    Thromb Haemost; 2004 Nov; 92(5):1025-31. PubMed ID: 15543330
    [Abstract] [Full Text] [Related]

  • 25. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N, Guldiken S, Demir M, Tugrul A.
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491
    [Abstract] [Full Text] [Related]

  • 26. Impacts of laparoscopic hysterectomy on functions of coagulation and fibrinolysis system.
    Zhao H, Xiao W, Hu C, Gao X, Zhu Y, Yang X.
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):365-9. PubMed ID: 26761585
    [Abstract] [Full Text] [Related]

  • 27. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I.
    Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
    [Abstract] [Full Text] [Related]

  • 28. [Thrombin activatable fibrinolysis o inhibitor-TAFI- in dialyzed patients with diabetic nephropathy].
    Małyszko JS, Małyszko J, Hryszko T, Myśliwiec M.
    Pol Arch Med Wewn; 2003 Aug; 110(2):843-8. PubMed ID: 14682222
    [Abstract] [Full Text] [Related]

  • 29. Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels.
    Santamaría A, Oliver A, Borrell M, Mateo J, Belvis R, Martí-Fábregas J, Ortín R, Tirado I, Souto JC, Fontcuberta J.
    Stroke; 2003 Oct; 34(10):2387-91. PubMed ID: 12947154
    [Abstract] [Full Text] [Related]

  • 30. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
    Małyszko J, Małyszko JS, Hryszko T, Myśliwiec M.
    Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
    [Abstract] [Full Text] [Related]

  • 31. [Significance of Tissue Factor-Bearing Microparticle Procoagulation Activity and Antithrombin Ⅲ Detection in Thalassemia Patients].
    Su X, Liu H, Sun N, Cheng P, Deng DH, Long Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):539-544. PubMed ID: 30998167
    [Abstract] [Full Text] [Related]

  • 32. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.
    Akinci B, Comlekci A, Ali Ozcan M, Demir T, Yener S, Demirkan F, Yuksel F, Yesil S.
    Endocr J; 2007 Feb; 54(1):45-52. PubMed ID: 17090955
    [Abstract] [Full Text] [Related]

  • 33. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A, Jurkowski P, Kotschy M, Ciecierski M, Jawień A.
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [Abstract] [Full Text] [Related]

  • 34. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
    Lau HK, Segev A, Hegele RA, Sparkes JD, Teitel JM, Chisholm RJ, Strauss BH.
    Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
    [Abstract] [Full Text] [Related]

  • 35. Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients.
    Bavbek N, Ceri M, Akdeniz D, Kargili A, Duranay M, Erdemli K, Akcay A, Guz G.
    Ren Fail; 2014 Jun; 36(5):743-7. PubMed ID: 24580410
    [Abstract] [Full Text] [Related]

  • 36. Study of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with β-thalassemia.
    Fayed MA, Abdel-Hady HE, Hafez MM, Salama OS, Al-Tonbary YA.
    Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):65-74. PubMed ID: 28633041
    [Abstract] [Full Text] [Related]

  • 37. A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study.
    Altin N, Tiğlioğlu P, Ulusoy TU, Aydin FN, Kar İ, Karakoc B, Utebey G.
    Medicine (Baltimore); 2024 Apr 12; 103(15):e37802. PubMed ID: 38608056
    [Abstract] [Full Text] [Related]

  • 38. Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential.
    Colucci M, Cattaneo M, Martinelli I, Semeraro F, Binetti BM, Semeraro N.
    J Thromb Haemost; 2008 Sep 12; 6(9):1571-7. PubMed ID: 18624976
    [Abstract] [Full Text] [Related]

  • 39. Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke.
    Montaner J, Ribó M, Monasterio J, Molina CA, Alvarez-Sabín J.
    Stroke; 2003 Apr 12; 34(4):1038-40. PubMed ID: 12649517
    [Abstract] [Full Text] [Related]

  • 40. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
    Antovic JP, Rafik Hamad R, Antovic A, Blombäck M, Bremme K.
    Thromb Haemost; 2002 Oct 12; 88(4):644-7. PubMed ID: 12362237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.